Emergence of the Primary Pediatric Stroke Center : impact of the Thrombolysis in Pediatric Stroke ( TIPS ) Trial 2

In adult stroke, clinical trials have resulted in 2 evidencebased acute stroke treatment guidelines that save lives and improve neurological outcome: the use of tissue-type plasminogen activator (tPA) and the development of dedicated stroke units that provide standardized, best practice acute care. Following the approval of tPA for the treatment Background and Purpose—In adult stroke, the advent of thrombolytic therapy led to the development of primary stroke centers capable to diagnose and treat patients with acute stroke rapidly. We describe the development of primary pediatric stroke centers through preparation of participating centers in the Thrombolysis in Pediatric Stroke (TIPS) trial. Methods—We collected data from the 17 enrolling TIPS centers regarding the process of becoming an acute pediatric stroke center with capability to diagnose, evaluate, and treat pediatric stroke rapidly, including use of thrombolytic therapy. Results—Before 2004, <25% of TIPS sites had continuous 24-hour availability of acute stroke teams, MRI capability, or stroke order sets, despite significant pediatric stroke expertise. After TIPS preparation, >80% of sites now have these systems in place, and all sites reported increased readiness to treat a child with acute stroke. Use of a 1to 10-Likert scale on which 10 represented complete readiness, median center readiness increased from 6.2 before site preparation to 8.7 at the time of site activation (P≤0.001). Conclusions—Before preparing for TIPS, centers interested in pediatric stroke had not developed systematic strategies to diagnose and treat acute pediatric stroke. TIPS trial preparation has resulted in establishment of pediatric acute stroke centers with clinical and system preparedness for evaluation and care of children with acute stroke, including use of a standardized protocol for evaluation and treatment of acute arterial stroke in children that includes use of intravenous tissue-type plasminogen activator. Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01591096. (Stroke. 2014;45:2018-2023.)

[1]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[2]  R E Latchaw,et al.  Recommendations for the establishment of primary stroke centers , 2000 .

[3]  Sidney C. Smith,et al.  Recommendations for Improving the Quality of Care Through Stroke Centers and Systems: An Examination of Stroke Center Identification Options: Multidisciplinary Consensus Recommendations From the Advisory Working Group on Stroke Center Identification Options of the American Stroke Association , 2002, Stroke.

[4]  F. Kirkham,et al.  Diagnostic pitfalls in paediatric ischaemic stroke. , 2006, Developmental medicine and child neurology.

[5]  A. Qureshi,et al.  Thrombolysis for Ischemic Stroke in Children: Data From the Nationwide Inpatient Sample , 2007, Stroke.

[6]  V. Ganesan,et al.  Delays in investigation and management of acute arterial ischaemic stroke in children , 2008, Developmental medicine and child neurology.

[7]  F. Silver,et al.  Delay to Diagnosis in Acute Pediatric Arterial Ischemic Stroke , 2009, Stroke.

[8]  Steven P. Miller,et al.  Delayed Recognition of Initial Stroke in Children: Need for Increased Awareness , 2009, Pediatrics.

[9]  S. Kasner,et al.  Interrater Reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a Multicenter Study , 2011, Stroke.

[10]  D. Bravata,et al.  Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[11]  Michael T. Mullen,et al.  Concurrent Validity and Reliability of Retrospective Scoring of the Pediatric National Institutes of Health Stroke Scale , 2012, Stroke.

[12]  S. Vesely,et al.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[13]  Eric E. Smith,et al.  Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department. , 2013, Annals of emergency medicine.